Renalytix plc, a company that uses artificial intelligence to diagnose and treat kidney disease, has announced that it is considering selling itself or its assets after receiving an unsolicited takeover offer from a larger competitor. The company, which is listed on both the London Stock Exchange and the Nasdaq, said that it has launched a…
Tag: Renalytix
St. Joseph’s Health and Renalytix partner to advance kidney health in New York
NEW YORK: St. Joseph’s Health and Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced a partnership to implement an advanced clinical care model designed to improve kidney health in patients with type 2 diabetes and early-stage chronic kidney disease. The Renalytix KidneyIntelX platform will be integrated with St. Joseph’s Health care management to help prevent patients with diabetes…